Facing diseases caused by trypanosomatid parasites: rational design of multifunctional oxidovanadium(IV) complexes with bioactive ligands
Frontiers in Chemical Biology · 2024
DOI: 10.3389/fchbi.2023.1304571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Chemical Biology, 2024. Verfasst von Gonzalo Scalese und 7 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Searching for new prospective drugs against Chagas disease (American trypanosomiasis) and Leishmaniasis, a series of five heteroleptic vanadium compounds, [V IV O(L-H)(mpo)], where L are 8-hydroxyquinoline derivatives and mpo is 2-mercaptopyridine N -oxide, are synthesized and characterized. Comprehensive characterizations are conducted in solid state and in solution. The compounds are evaluated on epimastigotes and trypomastigotes of Trypanosoma cruzi and in promastigotes of Leishmania infantum , alongside on VERO cells, as a mammalian cell model. The compounds exhibit activity against both forms of T. cruzi and promastigotes of L. infantum , with the trypomastigote infective stage of T. cruzi displaying the highest sensitivity. The most selective vanadium compound [V IV O(L2-H)(mpo)], with L2 = 5-chloro-7-iodo-8-hydroxyquinoline, globally shows adequate selectivity towards the parasite and was selected to carry out further in-depth biological studies. [V IV O(L2-H)(mpo)] significantly impacted the infection potential of cell-derived trypomastigotes and hindered the replication of the T. cruzi amastigote form. Low total vanadium uptake by T. cruzi parasites and preferential accumulation in the soluble proteins fraction, with negligible localization in the DNA fraction, are determined. A trypanocide effect is observed across various concentrations of the compound. The generation of oxidative stress and the induction of mitochondria-dependent apoptosis are proposed as the main mechanisms of the parasite’s death by the V IV O compounds. Both theoretical predictions and experimental data support the hypothesis that inhibiting the parasite-specific enzyme NADH-fumarate reductase activity plays a crucial role in the trypanocidal action of these complexes. Globally, [V IV O(L-H)(mpo)] complexes could be considered interesting anti- T. cruzi agents that deserve further research.
Zitieren
APA
Scalese, G., Machado, I., Salazar, F., Coitiño, E. L., Correia, I., Pessoa, J. C., Pérez-Díaz, L., & Gambino, D. (2024). Facing diseases caused by trypanosomatid parasites: rational design of multifunctional oxidovanadium(IV) complexes with bioactive ligands. Frontiers in Chemical Biology. https://doi.org/10.3389/fchbi.2023.1304571
Vancouver
Scalese G, Machado I, Salazar F, Coitiño EL, Correia I, Pessoa JC, et al. Facing diseases caused by trypanosomatid parasites: rational design of multifunctional oxidovanadium(IV) complexes with bioactive ligands. Frontiers in Chemical Biology. 2024. doi:10.3389/fchbi.2023.1304571
BibTeX
@article{Scalese2024,
author = {Scalese, Gonzalo and Machado, Ignacio and Salazar, Fabiana and Coitiño, E. Laura and Correia, Isabel and Pessoa, João Costa and Pérez-Díaz, Leticia and Gambino, Dinorah},
title = {Facing diseases caused by trypanosomatid parasites: rational design of multifunctional oxidovanadium(IV) complexes with bioactive ligands},
journal = {Frontiers in Chemical Biology},
year = {2024},
doi = {10.3389/fchbi.2023.1304571}
}
EUVIMED